ARKG 02/13/2024

ARK publishes a holdings file for each trading day that records how many shares each fund owns. The Shares Held column draws from these files: it displays today’s share count, and the number in parentheses shows the difference obtained by comparing today’s file with the previous trading day’s file.

#DateCompanyTickerCUSIPWeightShares HeldMarket Value
102/13/2024CRISPR THERAPEUTICS AGCRSPH171821087.20%1,791,451 (0) (0%)$136,938,514.44
202/13/2024EXACT SCIENCES CORPEXAS30063P1056.82%2,087,179 (-8,642) (-0.41%)$129,592,944.11
302/13/2024TWIST BIOSCIENCE CORPTWST90184D1005.95%2,787,021 (0) (0%)$113,180,922.81
402/13/2024RECURSION PHARMACEUTICALS-ARXRX75629V1045.15%8,950,859 (0) (0%)$97,922,397.46
502/13/2024ACCOLADE INCACCD00437E1024.36%5,957,050 (0) (0%)$82,922,136.00
602/13/2024TELADOC HEALTH INCTDOC87918A1054.32%3,893,751 (0) (0%)$82,158,146.10
702/13/2024PACIFIC BIOSCIENCES OF CALIFPACB69404D1084.16%11,778,646 (11,197) (0.1%)$79,034,714.66
802/13/2024GINKGO BIOWORKS HOLDINGS INCDNA37611X1004.12%51,865,722 (0) (0%)$78,317,240.22
902/13/2024IONIS PHARMACEUTICALS INCIONS4622221004.02%1,518,194 (0) (0%)$76,486,613.72
1002/13/2024SCHRODINGER INCSDGR80810D1034.01%2,673,342 (0) (0%)$76,216,980.42
1102/13/2024BEAM THERAPEUTICS INCBEAM07373V1054.00%2,277,664 (0) (0%)$76,073,977.60
1202/13/2024ARCTURUS THERAPEUTICS HOLDINARCT UQ03969T1093.93%1,794,062 (0) (0%)$74,668,860.44
1302/13/202410X GENOMICS INC-CLASS ATXG88025U1093.65%1,414,195 (19,147) (1.37%)$69,451,116.45
1402/13/2024INTELLIA THERAPEUTICS INCNTLA45826J1053.48%2,234,314 (0) (0%)$66,158,037.54
1502/13/2024CAREDX INCCDNA14167L1032.97%6,225,758 (0) (0%)$56,467,625.06
1602/13/2024VERACYTE INCVCYT92337F1072.79%2,003,010 (0) (0%)$53,119,825.20
1702/13/2024ADAPTIVE BIOTECHNOLOGIESADPT00650F1092.31%11,217,880 (0) (0%)$43,974,089.60
1802/13/2024VERTEX PHARMACEUTICALS INCVRTX92532F1002.29%103,926 (0) (0%)$43,496,148.78
1902/13/2024VEEVA SYSTEMS INC-CLASS AVEEV9224751082.28%198,566 (0) (0%)$43,378,728.36
2002/13/2024VERVE THERAPEUTICS INCVERV92539P1012.12%3,006,930 (0) (0%)$40,383,069.90
2102/13/2024UIPATH INC – CLASS APATH90364P1051.81%1,283,087 (0) (0%)$34,489,378.56
2202/13/2024STANDARD BIOTOOLS INCLAB34385P1081.74%13,842,896 (0) (0%)$33,084,521.44
2302/13/2024MODERNA INCMRNA60770K1071.68%359,184 (0) (0%)$31,967,376.00
2402/13/2024908 DEVICES INCMASS65443P1021.52%3,760,698 (0) (0%)$28,844,553.66
2502/13/2024INCYTE CORPINCY45337C1021.42%465,715 (0) (0%)$26,936,955.60
2602/13/2024NURIX THERAPEUTICS INCNRIX67080M1031.38%2,796,690 (0) (0%)$26,204,985.30
2702/13/2024COMPASS PATHWAYS PLCCMPS20451W1011.36%2,294,308 (0) (0%)$25,902,737.32
2802/13/2024REPARE THERAPEUTICS INCRPTX7602731021.27%2,870,912 (0) (0%)$24,144,369.92
2902/13/2024QUANTUM-SI INCQSI74765K1051.26%13,555,451 (0) (0%)$23,857,593.76
3002/13/2024REGENERON PHARMACEUTICALSREGN75886F1071.10%22,145 (0) (0%)$20,972,643.70
3102/13/2024PRIME MEDICINE INCPRME74168J1011.00%2,602,574 (0) (0%)$18,972,764.46
3202/13/2024NVIDIA CORPNVDA67066G1040.97%25,557 (0) (0%)$18,464,421.36
3302/13/2024CERUS CORPCERS1570851010.76%6,124,294 (0) (0%)$14,514,576.78
3402/13/2024AMGEN INCAMGN0311621000.68%43,632 (0) (0%)$12,846,569.76
3502/13/2024BUTTERFLY NETWORK INCBFLY1241551020.64%11,991,035 (0) (0%)$12,230,855.70
3602/13/2024GUARDANT HEALTH INCGH40131M1090.47%383,356 (0) (0%)$8,905,359.88
3702/13/2024PERSONALIS INCPSNL71535D1060.39%5,556,505 (0) (0%)$7,445,716.70
3802/13/2024GOLDMAN FS TRSY OBLIG INST 468X9USDGSFT0.25%4,798,488 (1,001,663) (26.38%)$4,798,487.86
3902/13/2024PFIZER INCPFE7170811030.18%122,060 (0) (0%)$3,376,179.60
4002/13/2024ABSCI CORPABSI00091E1090.11%458,829 (0) (0%)$2,083,083.66
4102/13/2024SENTI BIOSCIENCES INCSNTI81726A1000.04%1,714,794 (0) (0%)$746,106.87
4202/13/2024Senti Bio – place holdersharesDNBLFB2Y20.01%243,471 (0) (0%)$105,934.23
4302/13/2024INVITAE CORPNVTA46185L1030.00%3,920 (0) (0%)$146.61
Source: https://assets.ark-funds.com/fund-documents/funds-etf-csv/ARK_GENOMIC_REVOLUTION_ETF_ARKG_HOLDINGS.csv

Discover more from ARK Invest Daily Trades Tracker

Subscribe to get the latest posts sent to your email.

Leave a Comment